TNFα signalling predicts poor prognosis of patients with endometrial cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TNFα signalling predicts poor prognosis of patients with endometrial cancer
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-04-03
DOI
10.1093/carcin/bgaa034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer
- (2019) Christine Degasper et al. TUMOR BIOLOGY
- Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer
- (2019) Verena Wieser et al. CANCER SCIENCE
- Use of aspirin, other nonsteroidal anti-inflammatory drugs and acetaminophen and risk of endometrial cancer: the Epidemiology of Endometrial Cancer Consortium
- (2018) P M Webb et al. ANNALS OF ONCOLOGY
- Supervised Clustering of Adipokines and Hormonal Receptors Predict Prognosis in a Population of Obese Women with Type 1 Endometrial Cancer
- (2017) Jennifer Uzan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SPATA2 links CYLD to the TNF‐α receptor signaling complex and modulates the receptor signaling outcomes
- (2016) Sebastian A Wagner et al. EMBO JOURNAL
- SPATA2 promotes CYLD activity and regulates TNF‐induced NF‐κB signaling and cell death
- (2016) Lisa Schlicher et al. EMBO REPORTS
- Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial
- (2016) Britton Trabert et al. INTERNATIONAL JOURNAL OF CANCER
- Endometrial cancer
- (2016) Philippe Morice et al. LANCET
- SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
- (2016) Paul R. Elliott et al. MOLECULAR CELL
- SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
- (2016) Sebastian Kupka et al. Cell Reports
- USA Endometrial Cancer Projections to 2030: should we be concerned?
- (2014) M Aamir Sheikh et al. Future Oncology
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Hormonal, Metabolic, and Inflammatory Profiles and Endometrial Cancer Risk Within the EPIC Cohort—A Factor Analysis
- (2013) Laure Dossus et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Case–control study of inflammatory markers and the risk of endometrial cancer
- (2012) Christine M. Friedenreich et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancer risk: The EPIC study
- (2010) Laure Dossus et al. INTERNATIONAL JOURNAL OF CANCER
- Inflammatory events in endometrial adenocarcinoma
- (2010) Alison E Wallace et al. JOURNAL OF ENDOCRINOLOGY
- Endometrial cancer invasion depends on cancer-derived tumor necrosis factor-α and stromal derived hepatocyte growth factor
- (2008) Dong Soon Choi et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Tumor Necrosis Factor-α on Estrogen Metabolism and Endometrial Cells: Potential Physiological and Pathological Relevance
- (2008) Salama A. Salama et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Human Tumour Necrosis Factor: Physiological and Pathological Roles in Placenta and Endometrium
- (2008) S. Haider et al. PLACENTA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation